The majority of traumatic brain injuries (TBIs), approximately 90%, are classified as mild
(mTBIs). Globally, an estimated 4 million injuries occur each year from concussions or …

Emerging evidence suggests that biofluid-based biomarkers have diagnostic and prognostic
potential in traumatic brain injuries (TBI). However, owing to the lack of a conceptual …

An easily accessible biomarker with good diagnostic power for patients with traumatic brain
injury (TBI) was needed to predict the short-term mortality. Studies have shown that platelet …

Mild traumatic brain injury (mTBI) is a common problem. Depending on diagnostic criteria,
13 to 62% of those patients develop persistent post-concussion symptoms (PPCS). The …

Concussion or mild traumatic brain injury (mTBI) in athletes can cause persistent symptoms,
known as post-concussion syndrome (PCS), and repeated injuries may increase the long …

Traumatic brain injury is a multifaceted condition that encompasses a spectrum of injuries:
contusions, axonal injuries in specific brain regions, edema, and hemorrhage. Brain injury …

Post-concussive symptoms are frequently reported by individuals who sustain mild traumatic
brain injuries (mTBIs) and subconcussive head impacts, even when evidence of intracranial …

Currently available epidemiological data shows that traumatic brain injury (TBI) represents
one of the leading causes of death that is associated with medico-legal practice, including …

Postconcussion syndrome (PCS) is one of the leading complications that may appear in
patients after mild head trauma. Every day, thousands of people, regardless of age, gender …

Traumatic brain injury (TBI) is a serious health concern and a leading cause of death in all
age groups, especially adults. Although the processes of prevention, lifestyle modification …